You are here: Industry Insights > Diabetes

News List

High Lipoprotein(a) Is Risk Factor for CVD in Type 1 Diabetes drugs
December 31, 2019
For patients with type 1 diabetes, lipoprotein(a) [Lp(a)] is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease ...
Bariatric Surgery in Teens May Cut Diabetic Kidney Disease Risk drugs
December 30, 2019
Among obese adolescents with type 2 diabetes, metabolic bariatric surgery is associated with decreased rates of hyperfiltration and elevated urinary albumin excretion (UAE) ...
HbA1c Minimally Adds to CVD Risk Prediction in Prediabetes drugs
December 27, 2019
For individuals with prediabetes, hemoglobin A1c (HbA1c) minimally adds to cardiovascular disease (CVD) risk prediction, according to a study published online December in?Diabetes Care.
Early-Onset CVD Rate Up for Children of Moms With Diabetes drugs
December 27, 2019
Children of mothers with diabetes have increased rates of early-onset cardiovascular disease (CVD), according to a study published online December in?The BMJ.
T2DM Risk Cut With Weight Loss Even in Nonoverweight People drugs
December 26, 2019
Losing weight is consistently associated with reduced type 2 diabetes risk across body mass index (BMI), family history, and genetic risk categories ...
Duration of Diabetes History Tied to Higher Short-Term Mortality Risk drugs
December 26, 2019
In older adults, long-standing diabetes has a substantial and independent effect on short-term mortality, according to a study published online in?Diabetes Care.
Endocrine Society Releases Hypoglycemia Performance Measures drugs
December 25, 2019
A new set of quality measures can help health care providers identify older adults with type 2 diabetes who are at increased risk for hypoglycemia, according to an article published online in the?Journal of Clinical Endocrinology & Metabolism.
Prenatal Smoking Raises Risk for Gestational Diabetes Mellitus drugs
December 25, 2019
Prenatal smoking is associated with higher odds of gestational diabetes mellitus, even after adjusting for other known risk factors, according to a study published in the January issue of?Obstetrics & Gynecology.
Rezolute Announces Results from AB101 Trial Evaluating Diabetes Treatment americanpharmaceuticalreview
December 23, 2019
Rezolute announced top-line results from its Phase 1 trial of AB101, an ultra-long acting basal insulin for potential use in patients with type 1 and type 2 diabetes.
Low-Dose Aspirin May Cut Dementia Risk in Women With Diabetes drugs
December 19, 2019
Long-term use of low-dose aspirin may reduce the risk for dementia in women with type 2 diabetes, according to a study published online in?Diabetes Care.